Your browser doesn't support javascript.
loading
Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT.
Masouridi-Levrat, Stavroula; Olavarria, Eduardo; Iacobelli, Simona; Aljurf, Mahmoud; Morozova, Elena; Niittyvuopio, Riitta; Sengeloev, Henrik; Reményi, Peter; Helbig, Grzegorz; Browne, Paul; Ganser, Arnold; Nagler, Arnon; Snowden, John A; Robin, Marie; Passweg, Jakob; Van Gorkom, Gwendolyn; Wallet, Hélène Labussière; Hoek, Jennifer; Blok, Henric-Jan; De Witte, Theo; Kroeger, Nicolaus; Hayden, Patrick; Chalandon, Yves; Agha, Ibrahim Yakoub.
Afiliação
  • Masouridi-Levrat S; Hematology Division and Faculty of Medicine, University Hospitals of Geneva, University of Geneva, Geneva, Switzerland. stavroula.masouridi@hcuge.ch.
  • Olavarria E; Hammersmith Hospital, London, UK.
  • Iacobelli S; University of Rome "Tor Vergata", Rome, Italy.
  • Aljurf M; King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
  • Morozova E; First Pavlov State Medical University of St. Petersburg, St. Petersburg, Russia.
  • Niittyvuopio R; HUCH Comprehensive Cancer Center, Helsinki, Finland.
  • Sengeloev H; Bone Marrow Transplant Unit L 4043, Copenhagen, Denmark.
  • Reményi P; Dél-pesti Centrumkórház, Budapest, Hungary.
  • Helbig G; Silesian Medical Academy, Katowice, Poland.
  • Browne P; Hope Directorate, Dublin, Ireland.
  • Ganser A; Hannover Medical School, Hannover, Germany.
  • Nagler A; Chaim Sheba Medical Center, Tel-Hashomer, Israel.
  • Snowden JA; Sheffield Teaching Hospitals NHS Trust, Sheffield, UK.
  • Robin M; Hopital St. Louis, Paris, France.
  • Passweg J; University Hospital, Basel, Switzerland.
  • Van Gorkom G; Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Wallet HL; Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, France.
  • Hoek J; EBMT Data Office Leiden, Leiden, The Netherlands.
  • Blok HJ; EBMT Data Office Leiden, Leiden, The Netherlands.
  • De Witte T; Nijmegen Medical Centre, Radboud University, Nijmegen, Netherlands.
  • Kroeger N; Department of Stem Cell Transplantation, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Hayden P; St. James's Hospital, Dublin, Ireland.
  • Chalandon Y; Hematology Division and Faculty of Medicine, University Hospitals of Geneva, University of Geneva, Geneva, Switzerland.
  • Agha IY; CHU de Lille, Univ Lille, INSERM U1286, Infinite, 59000, Lille, France.
Bone Marrow Transplant ; 57(1): 23-30, 2022 01.
Article em En | MEDLINE | ID: mdl-34599284
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans / Middle aged Idioma: En Revista: Bone Marrow Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suíça País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans / Middle aged Idioma: En Revista: Bone Marrow Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suíça País de publicação: Reino Unido